BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 9229772)

  • 1. Signaling vascular morphogenesis and maintenance.
    Hanahan D
    Science; 1997 Jul; 277(5322):48-50. PubMed ID: 9229772
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial receptor tyrosine kinases involved in blood vessel development and tumor angiogenesis.
    Breier G
    Adv Exp Med Biol; 2000; 476():57-66. PubMed ID: 10949655
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.
    Maisonpierre PC; Suri C; Jones PF; Bartunkova S; Wiegand SJ; Radziejewski C; Compton D; McClain J; Aldrich TH; Papadopoulos N; Daly TJ; Davis S; Sato TN; Yancopoulos GD
    Science; 1997 Jul; 277(5322):55-60. PubMed ID: 9204896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubes, branches, and pillars: the many ways of forming a new vasculature.
    Augustin HG
    Circ Res; 2001 Oct; 89(8):645-7. PubMed ID: 11597985
    [No Abstract]   [Full Text] [Related]  

  • 5. Placental defects in ARNT-knockout conceptus correlate with localized decreases in VEGF-R2, Ang-1, and Tie-2.
    Abbott BD; Buckalew AR
    Dev Dyn; 2000 Dec; 219(4):526-38. PubMed ID: 11084652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
    Taylor AP; Osorio L; Craig R; Raleigh JA; Ying Z; Goldenberg DM; Blumenthal RD
    Clin Cancer Res; 2002 Apr; 8(4):1213-22. PubMed ID: 11948135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor links blood vessels, axons.
    Roush W
    Science; 1998 Mar; 279(5359):2042. PubMed ID: 9537914
    [No Abstract]   [Full Text] [Related]  

  • 8. Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver.
    Sato T; El-Assal ON; Ono T; Yamanoi A; Dhar DK; Nagasue N
    J Hepatol; 2001 May; 34(5):690-8. PubMed ID: 11434615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
    Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
    Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia.
    Zhang ZG; Zhang L; Tsang W; Soltanian-Zadeh H; Morris D; Zhang R; Goussev A; Powers C; Yeich T; Chopp M
    J Cereb Blood Flow Metab; 2002 Apr; 22(4):379-92. PubMed ID: 11919509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.
    Stratmann A; Acker T; Burger AM; Amann K; Risau W; Plate KH
    Int J Cancer; 2001 Feb; 91(3):273-82. PubMed ID: 11169947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.
    Zachary I; Gliki G
    Cardiovasc Res; 2001 Feb; 49(3):568-81. PubMed ID: 11166270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
    Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.
    Waltenberger J; Claesson-Welsh L; Siegbahn A; Shibuya M; Heldin CH
    J Biol Chem; 1994 Oct; 269(43):26988-95. PubMed ID: 7929439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxia.
    Christensen RA; Fujikawa K; Madore R; Oettgen P; Varticovski L
    J Cell Biochem; 2002; 85(3):505-15. PubMed ID: 11967990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
    Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
    Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
    Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.
    Asahara T; Chen D; Takahashi T; Fujikawa K; Kearney M; Magner M; Yancopoulos GD; Isner JM
    Circ Res; 1998 Aug; 83(3):233-40. PubMed ID: 9710115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis.
    Goede V; Schmidt T; Kimmina S; Kozian D; Augustin HG
    Lab Invest; 1998 Nov; 78(11):1385-94. PubMed ID: 9840613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial receptor tyrosine kinases involved in angiogenesis.
    Mustonen T; Alitalo K
    J Cell Biol; 1995 May; 129(4):895-8. PubMed ID: 7538139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.